Double antibiotic attack on staph blood infections shows promise
NCT ID NCT07148960
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests whether giving two IV antibiotics early, instead of one, can clear Staphylococcus aureus bloodstream infections faster and improve outcomes. About 300 hospitalized adults will be randomly assigned to receive either a single antibiotic or a combination of two. Once the infection clears, patients switch to oral antibiotics and are followed for 12 weeks after discharge.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
antibiotics (daptomycin, ceftaroline, rifampin, cefazolin, ertapenem, vancomycin)
What this could lead to
If it works, this could show that starting two IV antibiotics early helps clear Staph blood infections faster and reduces complications.
What could go wrong
This is a Phase 4 trial, but results may not apply to all hospitals or patients. Adding more antibiotics can raise the risk of side effects or drug resistance.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STAPHYLOCOCCUS AUREUS BACTEREMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
West Virginia University
Morgantown, West Virginia, 26506, United States